These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17308799)

  • 41. The Schistosoma bovis Sb14-3-3zeta recombinant protein cross-protects against Schistosoma mansoni in BALB/c mice.
    Siles-Lucas M; Uribe N; López-Abán J; Vicente B; Orfao A; Nogal-Ruiz JJ; Feliciano AS; Muro A
    Vaccine; 2007 Oct; 25(41):7217-23. PubMed ID: 17707955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kunitz-type protease inhibitor as a vaccine candidate against schistosomiasis mansoni.
    Ranasinghe SL; Duke M; Harvie M; McManus DP
    Int J Infect Dis; 2018 Jan; 66():26-32. PubMed ID: 29128645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni.
    Boulanger D; Reid GD; Sturrock RF; Wolowczuk I; Balloul JM; Grezel D; Pierce RJ; Otieno MF; Guerret S; Grimaud JA
    Parasite Immunol; 1991 Sep; 13(5):473-90. PubMed ID: 1956696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite.
    Wynn TA; Reynolds A; James S; Cheever AW; Caspar P; Hieny S; Jankovic D; Strand M; Sher A
    J Immunol; 1996 Nov; 157(9):4068-78. PubMed ID: 8892641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccination of mice with a 30 kDa Schistosoma antigen with and without human adjuvant induces high protection against S. mansoni infection.
    Attallah AM; Abdel Aziz MM; Abbas AT; Elbakry KA; El-Sharabasy MM
    J Helminthol; 2004 Sep; 78(3):189-94. PubMed ID: 15469619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of protective immunity induced against Schistosoma mansoni via DNA priming with the large subunit of calpain (Sm-p80) in the presence of genetic adjuvants.
    Siddiqui AA; Pinkston JR; Quinlin ML; Kavikondala V; Rewers-Felkins KA; Phillips T; Pompa J
    Parasite; 2005 Mar; 12(1):3-8. PubMed ID: 15828575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Papain-Based Vaccination Modulates Schistosoma mansoni Infection-Induced Cytokine Signals.
    Abdel Aziz N; Tallima H; Hafez EA; El Ridi R
    Scand J Immunol; 2016 Feb; 83(2):128-38. PubMed ID: 26603950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protection against Schistosoma mansoni achieved by immunization with sonicated parasite.
    Horowitz S; Smolarsky M; Arnon R
    Eur J Immunol; 1982 Apr; 12(4):327-32. PubMed ID: 6178604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective effect and granuloma down-modulation promoted by RP44 antigen a fructose 1,6 bisphosphate aldolase of Schistosoma mansoni.
    Marques HH; Zouain CS; Torres CB; Oliveira JS; Alves JB; Goes AM
    Immunobiology; 2008; 213(5):437-46. PubMed ID: 18472052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunoprotection of mice against Schistosomiasis mansoni using solubilized membrane antigens.
    Sulbarán G; Noya O; Brito B; Ballén DE; Cesari IM
    PLoS Negl Trop Dis; 2013; 7(6):e2254. PubMed ID: 23818994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo induction of type 1 and 2 immune responses against protein antigens.
    Comoy EE; Capron A; Thyphronitis G
    Int Immunol; 1997 Apr; 9(4):523-31. PubMed ID: 9138012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of protective immunity of 28KD-GST as a vaccine against experimental Schistosoma mansoni.
    Hassan MM; Moustafa NE; El-Motayam MH; El-Settawy MA; Taha AA
    J Egypt Soc Parasitol; 2009 Aug; 39(2):403-12. PubMed ID: 19795747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment.
    Webster M; Fulford AJ; Braun G; Ouma JH; Kariuki HC; Havercroft JC; Gachuhi K; Sturrock RF; Butterworth AE; Dunne DW
    Infect Immun; 1996 Oct; 64(10):4042-6. PubMed ID: 8926066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves' hyperthyroidism.
    Nagayama Y; Watanabe K; Niwa M; McLachlan SM; Rapoport B
    J Immunol; 2004 Aug; 173(3):2167-73. PubMed ID: 15265954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adjuvanted
    Perera DJ; Hassan AS; Jia Y; Ricciardi A; McCluskie MJ; Weeratna RD; Ndao M
    Front Immunol; 2020; 11():605288. PubMed ID: 33304354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody reactivity against potato apyrase, a protein that shares epitopes with Schistosoma mansoni ATP diphosphohydrolase isoforms, in acute and chronically infected mice, after chemotherapy and reinfection.
    Faria-Pinto Pd; Montesano MA; Jacinto AA; Santos RS; Bordin FH; Ferreira AP; Penido ML; Coelho PM; Vasconcelos EG
    Mem Inst Oswaldo Cruz; 2010 Jul; 105(4):374-9. PubMed ID: 20721478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis.
    Balloul JM; Grzych JM; Pierce RJ; Capron A
    J Immunol; 1987 May; 138(10):3448-53. PubMed ID: 3106483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased immunogenicity and protection of recombinant Sm14 antigens by heat-killed Cutibacterium acnes in BALB/c mice infected with Schistosoma mansoni.
    Lam HYP; Huang SP; Liang TR; Wu WJ; Cheng PC; Chang KC; Peng SY
    Parasitol Int; 2022 Feb; 86():102446. PubMed ID: 34481947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of protective immunity against Schistosoma mansoni by a non-living vaccine. V. Effects of varying the immunization and infection schedule and site.
    James SL
    Parasite Immunol; 1987 Sep; 9(5):531-41. PubMed ID: 3120134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice.
    Yang W; Jackson DC; Zeng Q; McManus DP
    Vaccine; 2000 Aug; 19(1):103-13. PubMed ID: 10924792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.